Matches in SemOpenAlex for { <https://semopenalex.org/work/W2207877462> ?p ?o ?g. }
- W2207877462 endingPage "165" @default.
- W2207877462 startingPage "154" @default.
- W2207877462 abstract "Abstract Objective The diagnostic accuracy of cerebrospinal fluid ( CSF ) biomarkers for Alzheimer's disease ( AD ) must be improved before widespread clinical use. This study aimed to determine whether CSF A β 42/A β 40 and A β 42/A β 38 ratios are better diagnostic biomarkers of AD during both predementia and dementia stages in comparison to CSF A β 42 alone. Methods The study comprised three different cohorts ( n = 1182) in whom CSF levels of A β 42, A β 40, and A β 38 were assessed. CSF A β s were quantified using three different immunoassays (Euroimmun, Meso Scale Discovery, Quanterix). As reference standard, we used either amyloid ( 18 F‐flutemetamol) positron emission tomography ( PET ) imaging ( n = 215) or clinical diagnosis ( n = 967) of well‐characterized patients. Results When using three different immunoassays in cases with subjective cognitive decline and mild cognitive impairment, the CSF A β 42/A β 40 and A β 42/A β 38 ratios were significantly better predictors of abnormal amyloid PET than CSF A β 42. Lower A β 42, A β 42/A β 40, and A β 42/A β 38 ratios, but not A β 40 and A β 38, correlated with smaller hippocampal volumes measured by magnetic resonance imaging. However, lower A β 38, A β 40, and A β 42, but not the ratios, correlated with non‐ AD ‐specific subcortical changes, that is, larger lateral ventricles and white matter lesions. Further, the A β 42/A β 40 and A β 42/A β 38 ratios showed increased accuracy compared to A β 42 when distinguishing AD from dementia with Lewy bodies or Parkinson's disease dementia and subcortical vascular dementia, where all A β s (including A β 42) were decreased. Interpretation The CSF A β 42/A β 40 and A β 42/A β 38 ratios are significantly better than CSF A β 42 to detect brain amyloid deposition in prodromal AD and to differentiate AD dementia from non‐ AD dementias. The ratios reflect AD ‐type pathology better, whereas decline in CSF A β 42 is also associated with non‐AD subcortical pathologies. These findings strongly suggest that the ratios rather than CSF A β 42 should be used in the clinical work‐up of AD ." @default.
- W2207877462 created "2016-06-24" @default.
- W2207877462 creator A5023889784 @default.
- W2207877462 creator A5024645775 @default.
- W2207877462 creator A5025313057 @default.
- W2207877462 creator A5025686564 @default.
- W2207877462 creator A5045343267 @default.
- W2207877462 creator A5049277633 @default.
- W2207877462 creator A5050302864 @default.
- W2207877462 creator A5073478649 @default.
- W2207877462 creator A5080476940 @default.
- W2207877462 creator A5083219599 @default.
- W2207877462 creator A5091785793 @default.
- W2207877462 date "2016-01-01" @default.
- W2207877462 modified "2023-10-17" @default.
- W2207877462 title "<scp>CSF</scp> A <i>β</i> 42/A <i>β</i> 40 and A <i>β</i> 42/A <i>β</i> 38 ratios: better diagnostic markers of Alzheimer disease" @default.
- W2207877462 cites W1208364757 @default.
- W2207877462 cites W1683475716 @default.
- W2207877462 cites W1717946385 @default.
- W2207877462 cites W1847168837 @default.
- W2207877462 cites W1933780834 @default.
- W2207877462 cites W1964049915 @default.
- W2207877462 cites W1972025839 @default.
- W2207877462 cites W1976115853 @default.
- W2207877462 cites W1977477115 @default.
- W2207877462 cites W1991435932 @default.
- W2207877462 cites W1991600017 @default.
- W2207877462 cites W1992165389 @default.
- W2207877462 cites W2004605168 @default.
- W2207877462 cites W2006617902 @default.
- W2207877462 cites W2008854521 @default.
- W2207877462 cites W2035440474 @default.
- W2207877462 cites W2046952010 @default.
- W2207877462 cites W2049421402 @default.
- W2207877462 cites W2049943618 @default.
- W2207877462 cites W2052453119 @default.
- W2207877462 cites W2054007740 @default.
- W2207877462 cites W2058161128 @default.
- W2207877462 cites W2063241172 @default.
- W2207877462 cites W2069440543 @default.
- W2207877462 cites W2071430831 @default.
- W2207877462 cites W2073809577 @default.
- W2207877462 cites W2075193321 @default.
- W2207877462 cites W2077299724 @default.
- W2207877462 cites W2084331437 @default.
- W2207877462 cites W2091539831 @default.
- W2207877462 cites W2096092665 @default.
- W2207877462 cites W2102848905 @default.
- W2207877462 cites W2103187247 @default.
- W2207877462 cites W2103861278 @default.
- W2207877462 cites W2104048700 @default.
- W2207877462 cites W2106599547 @default.
- W2207877462 cites W2119749118 @default.
- W2207877462 cites W2133649359 @default.
- W2207877462 cites W2146788881 @default.
- W2207877462 cites W2148080316 @default.
- W2207877462 cites W2149435570 @default.
- W2207877462 cites W2156981442 @default.
- W2207877462 cites W2161737267 @default.
- W2207877462 cites W2167311298 @default.
- W2207877462 cites W2170204731 @default.
- W2207877462 cites W2171573441 @default.
- W2207877462 cites W2173601762 @default.
- W2207877462 cites W4232960070 @default.
- W2207877462 doi "https://doi.org/10.1002/acn3.274" @default.
- W2207877462 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4774260" @default.
- W2207877462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27042676" @default.
- W2207877462 hasPublicationYear "2016" @default.
- W2207877462 type Work @default.
- W2207877462 sameAs 2207877462 @default.
- W2207877462 citedByCount "304" @default.
- W2207877462 countsByYear W22078774622016 @default.
- W2207877462 countsByYear W22078774622017 @default.
- W2207877462 countsByYear W22078774622018 @default.
- W2207877462 countsByYear W22078774622019 @default.
- W2207877462 countsByYear W22078774622020 @default.
- W2207877462 countsByYear W22078774622021 @default.
- W2207877462 countsByYear W22078774622022 @default.
- W2207877462 countsByYear W22078774622023 @default.
- W2207877462 crossrefType "journal-article" @default.
- W2207877462 hasAuthorship W2207877462A5023889784 @default.
- W2207877462 hasAuthorship W2207877462A5024645775 @default.
- W2207877462 hasAuthorship W2207877462A5025313057 @default.
- W2207877462 hasAuthorship W2207877462A5025686564 @default.
- W2207877462 hasAuthorship W2207877462A5045343267 @default.
- W2207877462 hasAuthorship W2207877462A5049277633 @default.
- W2207877462 hasAuthorship W2207877462A5050302864 @default.
- W2207877462 hasAuthorship W2207877462A5073478649 @default.
- W2207877462 hasAuthorship W2207877462A5080476940 @default.
- W2207877462 hasAuthorship W2207877462A5083219599 @default.
- W2207877462 hasAuthorship W2207877462A5091785793 @default.
- W2207877462 hasBestOaLocation W22078774621 @default.
- W2207877462 hasConcept C126322002 @default.
- W2207877462 hasConcept C126838900 @default.
- W2207877462 hasConcept C142724271 @default.
- W2207877462 hasConcept C143409427 @default.
- W2207877462 hasConcept C2775842073 @default.
- W2207877462 hasConcept C2777952318 @default.